The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
Author:
Affiliation:
1. University of Florida College of MedicineJacksonvilleFLUSA
2. Mayo ClinicJacksonvilleFLUSA
3. Cleveland ClinicWestonFLUSA
Funder
United Therapeutics Corporation
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1086/689291
Reference16 articles.
1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie N;Eur Heart J,2016
2. Prognostic factors in COPD patients receiving long‐term oxygen therapy. Importance of pulmonary artery pressure;Oswald‐Mammosser M;Chest,1995
3. Patterns of cardiovascular dysfunction in chronic obstructive lung disease;Burrows B;N Engl J Med,1972
4. Long‐term course of pulmonary arterial pressure in chronic obstructive pulmonary disease;Weitzenblum E;Am Rev Respir Dis,1984
5. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type;Oswald‐Mammosser M;Respiration,1991
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil;JHLT Open;2024-11
2. Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results;European Respiratory Journal;2024-05-29
3. Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review;Frontiers in Medicine;2023-08-29
4. Idiopathic Pulmonary Fibrosis: 8 Years On After Nintedanib and Pirfenidone Approval—What Is on the Horizon?;Current Pulmonology Reports;2023-06-20
5. Overview for Phenotypes and TCM Patterns on Chronic Obstructive Pulmonary Disease Complicated with Chronic Pulmonary Heart Disease;Traditional Chinese Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3